These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Risk factors of threshold retinopathy of prematurity.
    Author: Dutta S, Narang S, Narang A, Dogra M, Gupta A.
    Journal: Indian Pediatr; 2004 Jul; 41(7):665-71. PubMed ID: 15297681.
    Abstract:
    OBJECTIVE: To determine the risk factors which predispose to the development of threshold retinopathy of prematurity among patients of retinopathy of prematurity. METHODS: The ROP clinic records of a 3 year period were retrospectively studied to identify babies with threshold ROP (T-ROP) and sub-threshold ROP (ST-ROP). Various antenatal and perinatal risk factors, neonatal morbidity and therapeutic interventions were compared between the 2 groups. RESULTS: Of the total of 108 babies, 55 had T-ROP and 53 had ST-ROP. On univariate analysis, packed cell transfusions for anemia, double volume exchange transfusions (DVET), number of DVET, ventilation, gestational age <or= 28 weeks and apneic episodes were significantly higher in the T-ROP group. On multivariate analysis, the administration of packed cells [OR 2.8, 95 PERCENT CI 1.2, 6.6; (p = 0.014)] and DVET [OR 2.7, 95 PERCENT CI 1.2, 6.5; (p = 0.022)] emerged as independent risk factors of T-ROP. CONCLUSION: Administration of blood products increases the risk of developing T-ROP among patients who have ROP. There is a need to exercise caution in the use of blood products in premature newborns.
    [Abstract] [Full Text] [Related] [New Search]